Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

49.69 -0.06 (-0.13%)

Delayed Quote Updated: 9:53 AM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

November 15, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results

November 13, 2023

From Pulse Biosciences, Inc.

Via Business Wire

UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call

November 10, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Schedules Third Quarter 2023 Financial Results Conference Call for November 13, 2023

October 30, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Recap: Pulse Biosciences Q1 Earnings ↗

May 11, 2023

Via Benzinga

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Pulse Biosciences Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery

October 24, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study

October 02, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit

September 29, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting

September 27, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase

September 07, 2023

From Pulse Biosciences, Inc.

Via Business Wire

The Truth About IPO Investing ↗

September 02, 2023

When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are...

Via Talk Markets

Topics Initial Public Offering

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 29, 2023

Via Benzinga

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 29, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.

Via Benzinga

Topics Intellectual Property

Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 28, 2023

Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.

Via Benzinga

Pulse Biosciences Clarifies Details of Recent S-3 Filing

August 24, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results

August 10, 2023

From Pulse Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 28, 2023

Via Benzinga

Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023

July 27, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session ↗

July 31, 2023

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.

Via Benzinga

Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting

May 18, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results

May 11, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Over $65M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

May 11, 2023

Although US stocks closed mixed on Wednesday, there were a few notable insider trades.

Via Benzinga

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

May 10, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer

May 03, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces $65 Million Private Placement

May 01, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023

April 27, 2023

From Pulse Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 13, 2023

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.